Low-dose aminoglutethimide in treatment of advanced breast cancer. 1984

R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith

The clinical and endocrine effects of low-dose aminoglutethimide without hydrocortisone in patients with advanced breast cancer were investigated. In a dose escalation study low-dose aminoglutethimide alone (62.5-125 mg twice daily) was as effective as conventional doses with hydrocortisone in lowering serum oestrone and oestradiol concentrations but caused minimum adrenal inhibition, as assessed by serum dehydroepiandrosterone sulphate. 11 of 57 (19%) evaluable patients had tumour regression by objective criteria on this treatment, but the frequency of side-effects was similar to that with conventional doses. Low-dose aminoglutethimide is active in the treatment of breast cancer. It appears to work by inhibition of the aromatase enzyme system in peripheral tissues rather than adrenal suppression.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D003687 Dehydroepiandrosterone A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. Dehydroisoandrosterone,Prasterone,5-Androsten-3-beta-hydroxy-17-one,5-Androsten-3-ol-17-one,Androstenolone,DHEA,Prasterone, 3 alpha-Isomer,5 Androsten 3 beta hydroxy 17 one,5 Androsten 3 ol 17 one,Prasterone, 3 alpha Isomer
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004970 Estrone An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women. Folliculin (Hormone),Estrone, (+-)-Isomer,Estrone, (8 alpha)-Isomer,Estrone, (9 beta)-Isomer,Estrovarin,Kestrone,Unigen,Wehgen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000311 Adrenal Glands A pair of glands located at the cranial pole of each of the two KIDNEYS. Each adrenal gland is composed of two distinct endocrine tissues with separate embryonic origins, the ADRENAL CORTEX producing STEROIDS and the ADRENAL MEDULLA producing NEUROTRANSMITTERS. Adrenal Gland,Gland, Adrenal,Glands, Adrenal

Related Publications

R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith
February 1989, European journal of cancer & clinical oncology,
R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith
October 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith
January 1985, European journal of cancer & clinical oncology,
R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith
November 1984, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith
April 1985, British journal of cancer,
R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith
September 1984, Cancer treatment reviews,
R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith
January 1986, Breast cancer research and treatment,
R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith
October 1985, Tumori,
R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith
August 1982, Cancer research,
R Stuart-Harris, and M Dowsett, and T Bozek, and J A McKinna, and J C Gazet, and S L Jeffcoate, and A Kurkure, and L Carr, and I E Smith
January 1989, Cancer investigation,
Copied contents to your clipboard!